The New Clinical Investigation exclusivity: a substantial source of monopoly time for brand drugs

Authors: Robin Feldman, Gideon Schor, Ramy Alsaffar

Published: 2025-06-16

DOI: 10.1038/s41587-025-02696-8

Source: Full article


Abstract

No abstract found.